Molecular Forecaster

Molecular Forecaster

Research as a Service (RaaS) with CADD tech. and expertise
Canada
English, French
Academic affiliation

Molecular Forecaster has brought together its world-class CADD tools with a multidisciplinary team to widely address challenges encountered in early-stage drug discovery. We aim to support as many small molecule projects as possible. Growing since 2019, MFI was created out of 15 years of research at McGill University.

Individual
Company

Skills

Hit identification
Structure-based drug design
Covalent inhibitor chemistry
Virtual screening
Ligand-based drug design
Covalent library design
Combinatorial library design
GPCRs
Analog design
ADMET
Allosteric modulators

About

Chemical research is complex, dynamic, and challenging and computer-aided drug design can bolster the medicinal chemists toolbox. But software alone won’t save lives. For the best results, you need to combine sophisticated, practical tools with a level of research knowledge and expertise that’s often difficult to source.MFI’s team of computational, medicinal, and synthetic chemists are true partners, putting our software solutions into practice and delivering boutique CRO services designed to expand the drug design and discovery ecosystem for both clients and patients.We don’t believe in miracles. We believe the combination of sophisticated software, deep scientific knowledge, experience, passion, and above-and-beyond contract research services can – and does – produce miraculous results.We developed our model for client care with this in mind, consciously creating ourselves as a boutique contract research organization (CRO), uniquely qualified to make a difference. Our cutting-edge software outperforms the competition – we’ve got the results to prove it with computational modeling hit rates of 15-20% versus the 1% of traditional high-throughput screening.

Work experience

No items found.

Education

No items found.

Publications

Case STUDIES

Drug Discovery Partnership (Alchem Labs)

Structure-based drug design (Structural Genomics Consortium)

Virtual Library Design (Liverpool ChiroChem)